Wang Zhikui, Wang Zhaoxia, Zhou Zhongqi, Ren Yueqin
Department of Nephrology, Linyi People's Hospital, No.27 Jiefang Road, Lanshan District, Linyi, Shandong, 276003, China.
BMC Nephrol. 2016 Sep 9;17(1):128. doi: 10.1186/s12882-016-0343-2.
This study sought to investigate crucial genes correlated with diabetic nephropathy (DN), and their potential functions, which might contribute to a better understanding of DN pathogenesis.
The microarray dataset GSE1009 was downloaded from Gene Expression Omnibus, including 3 diabetic glomeruli samples and 3 healthy glomeruli samples. The differentially expressed genes (DEGs) were identified by LIMMA package. Their potential functions were then analyzed by the GO and KEGG pathway enrichment analyses using the DAVID database. Furthermore, miRNAs and transcription factors (TFs) regulating DEGs were predicted by the GeneCoDis tool, and miRNA-DEG-TF regulatory network was visualized by Cytoscape. Additionally, the expression of DEGs was validated using another microarray dataset GSE30528.
Totally, 14 up-regulated DEGs and 430 down-regulated ones were identified. Some DEGs (e.g. MTSS1, CALD1 and ACTN4) were markedly relative to cytoskeleton organization. Besides, some other ones were correlated with arrhythmogenic right ventricular cardiomyopathy (e.g. ACTN4, CTNNA1 and ITGB5), as well as complement and coagulation cascades (e.g. C1R and C1S). Furthermore, a series of miRNAs and TFs modulating DEGs were identified. The transcription factor LEF1 regulated the majority of DEGs, such as ITGB5, CALD1 and C1S. Hsa-miR-33a modulated 28 genes, such as C1S. Additionally, 143 DEGs (one upregulated gene and 142 downregulated genes) were also differentially expressed in another dataset GSE30528.
The genes involved in cytoskeleton organization, cardiomyopathy, as well as complement and coagulation cascades may be closely implicated in the progression of DN, via the regulation of miRNAs and TFs.
本研究旨在探究与糖尿病肾病(DN)相关的关键基因及其潜在功能,这可能有助于更好地理解DN的发病机制。
从基因表达综合数据库下载微阵列数据集GSE1009,其中包括3个糖尿病肾小球样本和3个健康肾小球样本。使用LIMMA软件包鉴定差异表达基因(DEG)。然后使用DAVID数据库通过GO和KEGG通路富集分析来分析其潜在功能。此外,通过GeneCoDis工具预测调控DEG的miRNA和转录因子(TF),并使用Cytoscape可视化miRNA-DEG-TF调控网络。另外,使用另一个微阵列数据集GSE30528验证DEG的表达。
共鉴定出14个上调的DEG和430个下调的DEG。一些DEG(如MTSS1、CALD1和ACTN4)与细胞骨架组织显著相关。此外,其他一些基因与致心律失常性右心室心肌病(如ACTN4、CTNNA1和ITGB5)以及补体和凝血级联反应(如C1R和C1S)相关。此外,还鉴定出一系列调控DEG的miRNA和TF。转录因子LEF1调控大多数DEG,如ITGB5、CALD1和C1S。Hsa-miR-33a调控28个基因,如C1S。另外,在另一个数据集GSE30528中也有143个DEG(1个上调基因和142个下调基因)差异表达。
参与细胞骨架组织、心肌病以及补体和凝血级联反应的基因可能通过miRNA和TF的调控与DN的进展密切相关。